India Probes Cough Syrup Link in Children's Deaths
Authorities in India are investigating the deaths of over 10 children in Madhya Pradesh and Rajasthan, with early signs pointing towards a link with a specific cough syrup. The syrup, Dextromethorphan Hydrobromide, is commonly supplied through government hospitals and has been manufactured by Kayson Pharma.
Five of the deceased children had consumed Coldref, while another had taken Nextro syrup, both containing Dextromethorphan Hydrobromide. Initial investigations ruled out water contamination and mosquito-related infections as causes of the illnesses. The drug regulator found no contamination in the cough syrup, but the syrup from Kayson Pharma has come under scrutiny following the child deaths in Rajasthan, particularly from the Sikar district.
Health departments have issued advisories to parents, doctors, and pharmacies to stay alert regarding the situation. The Rajasthan Medical Services Corporation (RMSCL) has banned the sale and use of 19 syrup batches. The National Centre for Disease Control (NCDC) is conducting detailed tests on drug, water, and entomological samples from affected areas. Over 1,400 children with flu-like symptoms are under active monitoring in the affected states.
Nine children died in Madhya Pradesh's Chhindwara district due to kidney failure, with similar cases reported in Rajasthan's Sikar district. Authorities suspect a link between the children's deaths and cough syrups, prompting statewide testing and a halt in the distribution of the drug. The situation remains under close scrutiny.
Read also:
- Trump's SNAP reductions and New York City Council's grocery delivery legislation: Problems for city residents highlighted
- Reducing dental expenses for elderlies in Sweden: Over 50% cut in charges for pensioners by the government
- Forty-year-old diet: A list of meal choices to savor
- Exiled Life's Conundrum: A Blend of Liberation, Disillusionment, and Distress
